Clearside Biomedical's total assets for Q1 2025 were $19.67M, a decrease of -21.72% from the previous quarter. CLSD total liabilities were $65.58M for the fiscal quarter, a 2.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.